Alligator Bioscience AB

Research Alligator Bioscience AB (ATORX) on Bullrun: market cap SEK 111.17M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerATORX
• ExchangeST
• CountrySweden
• SectorHealthcare
• IndustryBiotechnology
• CurrencySEK
• Market capSEK 111.17M
• Financial periodFY2024
• RevenueSEK 57.77M
• Revenue growth-0.6%
• Net income-SEK 233.89M
• Free cash flow-SEK 212.43M

Valuation Snapshot

latest market cap is SEK 111.17M.

About Alligator Bioscience AB

Alligator Bioscience AB (publ), a research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Belgium. The company develops Mitazalimab, a stimulatory antibody that targets CD40, which is in phase 3 clinical trial for the treatment of solid metastatic tumors, including pancreatic cancer;

Frequently asked questions

What is Alligator Bioscience AB's market cap?

Alligator Bioscience AB's market capitalization is SEK 111.17M.

What does Alligator Bioscience AB do?

Alligator Bioscience AB (publ), a research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Belgium.